Stemmatters lead product targets cartilage repair, bringing unique competitive and regulatory advantages as compared to other devices currently in the market or in late stage clinical development.

Our product is applied by a simple arthroscopic procedure avoiding use of biological glues or surgical suturing, minimizing surgical complexity and outcome variability.

As a minimally invasive procedure, our device is meant to support outpatient treatment and contribute to reduce the overall cost of treatment.